ÂÜÀòÂÒÂ×

Jorge Capapey MD, MBA is an experienced leader in the pharmaceutical industry, currently serving as the VP, Global Rare Diseases Lead at Alnylam Pharmaceuticals since September 2019, where responsibilities include developing and commercializing treatments for rare and ultra-rare diseases. Previously held roles include VP, Regional Commercial Head, and VP, Country Manager for Spain at Alnylam, where significant contributions included launching the orphan drug Onpattro. Jorge has also served as Vice President and President of AELMHU, advocating for patients with rare diseases. Earlier experience includes General Manager at Aegerion Pharmaceuticals, Global Medical Director at Boehringer Ingelheim, and various positions at Actelion. Jorge's educational background includes an MD from Universitat de Barcelona, an MBA from ESADE, and further studies at renowned institutions such as MIT Sloan School of Management.